CM Plus Singapore Pte. Ltd.
基本情報
- 所在地
- 11 North Buona Vista Drive, #08-09 (Servcorp) The Metropolis Tower 2, Singapore 138589
- 社長
- Tsunehiro Togashi
- 従業員数(単独)
- 従業員数(連結)
- 開始日
- 2007-08-17
- 終了日
サイト
事業内容
関連会社
| 会社名 | Group | 親会社 | 子会社 | 得意先 | 仕入先 | 業務提携 | 銀行等 | 株主等 |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
| Indonesia | ||||||||
|
|
||||||||
| Vietnam |
関連図
沿革
ニュース
CM Plus Singapore to Speak at GMP/EU-GMP Workshop 2026
CM Plus Singapore Pte. Ltd. will participate as a sponsor and presenter at the ISPE Singapore – VNPCA GMP Workshop 2026 in Ho Chi Minh City, Vietnam. The workshop is scheduled for November 5–6, 2026, and will focus on GMP practices in the pharmaceutical industry.
CM Plus Singapore to Exhibit at Regenerative Medicine JAPAN 2026
CM Plus Singapore Pte. Ltd. will exhibit at Regenerative Medicine JAPAN 2026, held at PACIFICO Yokohama from October 7 to 9, 2026. Individual consultations will be available during the event. President Hiroto Katayama and Yasuyuki Suga will give presentations.
CM Plus Relaunches Overseas Factory Site
On September 16, 2026, CM Plus fully renewed and relaunched its Overseas Factory Construction Information Platform, marking the first major overhaul since its launch in August 2020. The platform reorganizes accumulated research to help companies expand factories into Southeast Asia, making reliable on‑ground information easier to access. New column series by external experts with deep regional knowledge have also been introduced.
Microorganism Series – Part 4
The updated “Microorganism and Sterilization Management [2026]” column series has reached Part 4, continuing its 50‑part legacy on the GMP Platform. Part 4 focuses on the fundamentals of microbiology, building on earlier installments that cover foundational concepts and practical gaps for professionals.
PMDA Orange Letter Series Expands to Part 2
Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has released a new column series titled “PMDA Orange Letter,” now extending to Part 2. The series publishes anonymized, practical findings from GMP inspections to encourage voluntary quality improvements and proactive compliance at pharmaceutical manufacturing sites. Rather than merely listing violations, the articles focus on root causes and provide real‑world case studies based on the Japanese GMP Ministerial Order, covering all critical quality elements.
Seminar on Quality & Excipients
PT CMPlus Consulting Indonesia, in partnership with BADIKLAT Ikatan Apoteker Indonesia, hosted a webinar on June 30, 2026, to raise quality standards in the Central Java pharmaceutical sector. The session focused on navigating PIC/S GMP (CPOB) regulations and attracted mainly QA and QC specialists.
CM Plus & Memsift Deploy Circular Water
CM Plus and Memsift Innovations have signed a strategic Memorandum of Understanding to accelerate the deployment of next‑generation circular water infrastructure solutions across Japan and Southeast Asia. The partnership combines CM Plus’s engineering and project‑management expertise with Memsift’s advanced membrane and thermodynamic separation technologies. Together, they aim to enhance water reuse and sustainability in advanced manufacturing across the region.
iVEXL Interview Featured by IL
An interview article on iVEXL was highlighted as a case study on IL Contract Packaging’s official website and LinkedIn. The feature showcases the interview and links to the full article. Links to the IL Group website (English and Japanese) and LinkedIn post are provided.
CM Plus Group at ISPE Indonesia
CM Plus Group representatives Mr. Yahiro and Mr. Goto spoke at the ISPE Indonesia Annual Conference on May 12-13, 2026, presenting actionable insights on practical digitalization for existing plants, emphasizing AI‑driven optimization and carbon‑neutral strategies. The Q&A session highlighted a shared vision between Indonesian and Japanese manufacturing sectors to address modern industrial challenges. Through its local arm, PT. CMPLUS CONSULTING INDONESIA, the group will continue to drive innovation.